International pharmaceutical firm Angelini Pharma has initiated a creative crowdsourcing campaign aimed at enhancing target identification in epilepsy, particularly focusing on drug-resistant phenotypes.
The voluntary recall, originally initiated due to a product compliant in October 2018 for mislabeling, continues for anti-seizure drug, Levetiracetam injection in single-dose bags.
Two firms have announced a licence and supply agreement for a novel
formulation of valproic acid presented as a softgel capsule, which
could challenge Abbott's top selling drug Depakote (divalproex
sodium).
Indian firm Alembic has landed a licensing deal with biopharma
heavyweight UCB to apply the company's novel drug delivery system
for a once-a-day version of UCB's market leading epilepsy drug.
Researchers have identified the first gene in patients who have
epilepsy, which is associated with a movement disorder. The study
provides the first direct genetic evidence that the co-existence of
these conditions represents a new...
New research in the US, focusing on the pharmacological aspects of
smoking marijuana, are closer to understanding how the drugs active
ingredients exert its effects, paving the way for drugs that
selectively bind and block subtypes...
Formulation specialist TransForm Pharmaceuticals has licensed a
novel salt form of the antiepileptic drug topiramate to Johnson
& Johnson in a development that provides the first real
validation of its business model.
